Table 2.
Theme | Number of Intervention Studies (%) |
---|---|
Laws | |
Mandatory naloxone co-prescription with opioids | 1 (5.6%) [27] |
Standing order | 2 (11.1%) [21,24] |
Prescriptive authority | 4 (22.2%) [19,21,24,31] |
OTC status of naloxone | 1 (5.6%) [30] |
Education of pharmacy team prior to implementation | 10 (55.5%) [18,22,23,24,29,31,32,33,34,35] |
Interventions | |
PMS used to help flag patients eligible for naloxone | 3 (16.6%) [28,34,35] |
Checklists (patient eligibility, patient counselling) | 4 (22.2%) [22,25,29,34] |
Pocketcard | 1 (5.6%) [23] |
Patient brochure | 4 (22.2%) [20,22,34,35] |
Screening | 4 (22.2%) [26,32,33,34] |
Opt-out | 1 (5.6%) [25] |